NLM Gateway
A service of the U.S. National Institutes of Health
Your Entrance to
Resources from the
National Library of Medicine
    Home      Term Finder      Limits/Settings      Search Details      History      My Locker        About      Help      FAQ    
Skip Navigation Side Barintended for web crawlers only

Frequency of lipodystrophy and factors associated with glucose/lipid abnormalities in a cohort of 650 patients treated by protease inhibitors.

Gharakhanian S, Salhi Y, Nguyen TH, Adda N, Catrix S, Vigouroux C, Capeau J, Rozenbaum W; Conference on Retroviruses and Opportunistic Infections.

Program Abstr 6th Conf Retrovir Oppor Infect Conf Retrovir Oppor Infect 6th 1999 Chic Ill. 1999 Jan 31-Feb 4; 6th: 188 (abstract no. 642).

Rothschild Hospital, Paris, France.

Objective: A cross sectional study of clinical and laboratory abnormalities in protease inhibitor (PI) treated patients (pts). Patients and Methods: All pts in the AIDS clinic receiving PI*3 m underwent clinical evaluation of 14 signs,10 anthropometric measures, testing for cholesterol (C), triglyceride (TG), apolipoprotein B/A1, 75gr 2hr OGGT, determination of insulin resistance (IR) by insulinemia or homeostasis model assessment. Results: 650 pts have been consecutively evaluated since July 98,results on 300 pts (m/f 83%/17%) are analyzed. Pts are aged 40 +/- 9 yrs,34% had an AIDS-defining disease,CD4=303 c/mm3 [1-1333],HIV RNA <500 cp/ml in 65% of pts, were on PI since 18 +/- 9 m. Major clinical signs were selected according to frequency: facial, limb,or buttock atrophy, venomegaly, increased abdominal wall thickness, neck, breast or waist size. Three clinical types were identified: lipoatrophic (71%), truncal pseudo-obesity (62%), mixed (46%). Of these,37%,39%,34% were non IR and non GI. Frequency of diabetes: 8.9%,9.1%,9.4%;glucose intolerance (GI):30.8%,27.8%,35.3%;IR without GI:22%,23%,20.9%;.hyper TG (>1.7 mmol/l) 34%,46%,36%;hyper C (>6.7 mmol/l) 76%,76%,71%;in the 3 types respectively. Median duration of PI was in the similar range (17-20 m) in the 3 clinical types. Median baseline minus current HIV RNA & CD4+ was identical in the 3 types. The frequency of diabetes, GI, and IR was lower (10.5%,7.9%,10.5%,respectively) in PI treated pts not incluable in the 3 clinical groups. Conclusion: Patients with PI>3 m develop a lipodystrophy syndrom comprised of 3 clinical types: lipoatrophy, pseudo-obesity or mixed. Diabetes mellitus, glucose intolerance or insulin resistance is a significant feature of this syndrom and is associated with some degree of dyslipidemia.

Publication Types:
  • Meeting Abstracts
Keywords:
  • Acquired Immunodeficiency Syndrome
  • Cholesterol
  • Cross-Sectional Studies
  • Diabetes Mellitus
  • Diabetes Mellitus, Type 2
  • Glucose
  • Glucose Intolerance
  • HIV Infections
  • Humans
  • Hyperlipidemias
  • Insulin Resistance
  • Lipodystrophy
  • Obesity
  • Protease Inhibitors
  • Triglycerides
  • epidemiology
Other ID:
  • 20711877
UI: 102195407

From Meeting Abstracts




Contact Us
U.S. National Library of Medicine |  National Institutes of Health |  Health & Human Services
Privacy |  Copyright |  Accessibility |  Freedom of Information Act |  USA.gov